Castration-resistant prostate cancer is resensitized to androgen deprivation by autophagy-dependent apoptosis induced by blocking SKP2
Science Signaling · 17.12.2024 · 17 (867)
DOI: 10.1126/scisignal.adk4122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Signaling, erschienen am 17.12.2024. Verfasst von Sherly I Celada und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College, Nashville, TN 37208, USA. Hauptthemen laut MEDLINE: S-Phase Kinase-Associated Proteins, Autophagy, Prostatic Neoplasms, Castration-Resistant, Apoptosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NCI NIH HHS, NIMHD NIH HHS.
Abstract (Originalsprache)
Resistance to androgen receptor (AR)–targeted therapies for prostate cancer (PCa) is characteristic of an aggressive subtype called castration-resistant prostate cancer (CRPC) and is often associated with tumor relapse. Both relapse and poor prognosis in patients with CRPC are associated with increased abundance of the E3 ubiquitin ligase SKP2. Therefore, we investigated the therapeutic potential of combined inhibition of AR and SKP2 for CRPC. We found that combined targeting of AR and SKP2 with small-molecule inhibitors decreased proliferation in two CRPC cell lines in culture and in xenografts in humanized mice. Furthermore, combined therapy in mice markedly decreased the growth of Pten/Trp53 double-knockout tumors, a particularly invasive model of CRPC, whereas disruption of either AR or SKP2 alone only modestly suppressed their growth. Mechanistically, the inhibition of SKP2 in CRPC cells induced autophagy-dependent apoptosis and promoted luminal-associated phenotypes, which promoted responsiveness to AR-targeted therapy. These effects were further enhanced by coinhibition of AR and were not induced by the AR inhibitor alone. Our findings indicate that targeting both AR and SKP2 signaling pathways is necessary to treat CRPC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College, Nashville, TN 37208, USA.
- Department of Biological Sciences, Tennessee State University, Nashville, TN 37209, USA.
- Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
- Department of Pathology, Anatomy and Cell Biology, Meharry Medical College, Nashville, TN 37208, USA.
- Department of Pathology, University of Mississippi Medical Center, Jackson, MS 39216, USA.
- Department of Urology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
ORCID-Profile: Sherly I Celada, Guoliang Li, Lindsay J Celada, Thanigaivelan Kanagasabai, Wenfu Lu, LaKendria K Brown, Michael G Izban, Robert J Matusik, Xiaofei Wang
Förderung
- NCATS NIH HHS
- NCI NIH HHS
- NIMHD NIH HHS
- NCRR NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Celada, S. I., Li, G., Celada, L. J., Kanagasabai, T., Lu, W., Brown, L. K., Mark, Z. A., Izban, M. G., Ballard, B. R., Zhou, X., Adunyah, S. E., Matusik, R. J., Wang, X., & Chen, Z. (2024). Castration-resistant prostate cancer is resensitized to androgen deprivation by autophagy-dependent apoptosis induced by blocking SKP2. Science Signaling, 17(867). https://doi.org/10.1126/scisignal.adk4122
Vancouver
Celada SI, Li G, Celada LJ, Kanagasabai T, Lu W, Brown LK, et al. Castration-resistant prostate cancer is resensitized to androgen deprivation by autophagy-dependent apoptosis induced by blocking SKP2. Science Signaling. 2024;17(867). doi:10.1126/scisignal.adk4122
BibTeX
@article{Celada2024,
author = {Celada, Sherly I and Li, Guoliang and Celada, Lindsay J and Kanagasabai, Thanigaivelan and Lu, Wenfu and Brown, LaKendria K and Mark, Zaniya A and Izban, Michael G and Ballard, Billy R and Zhou, Xinchun and Adunyah, Samuel E and Matusik, Robert J and Wang, Xiaofei and Chen, Zhenbang},
title = {Castration-resistant prostate cancer is resensitized to androgen deprivation by autophagy-dependent apoptosis induced by blocking SKP2},
journal = {Science Signaling},
year = {2024},
volume = {17},
number = {867},
doi = {10.1126/scisignal.adk4122}
}
EUVIMED